Skip to main navigation Skip to search Skip to main content

Safety of retroviral gene marking with a truncated NGF receptor [1]

  • C. Bonini
  • , M. Grez
  • , C. Traversari
  • , F. Ciceri
  • , S. Marktel
  • , G. Ferrari
  • , M. Dinauer
  • , M. Sadat
  • , A. Aiuti
  • , S. Deola
  • , M. Radrizzani
  • , A. Hagenbeek
  • , J. Apperley
  • , S. Ebeling
  • , A. Martens
  • , H. J. Kolb
  • , M. Weber
  • , F. Lotti
  • , A. Grande
  • , E. Weissinger
  • J. A. Bueren, M. Lamana, J. H.F. Falkenburg, M. H.M. Heemskerk, T. Austin, S. Kornblau, F. Marini, C. Benati, Z. Magnani, S. Cazzaniga, S. Toma, C. Gallo-stampino, M. Introna, S. Slavin, P. D. Greenberg, M. Bregni, F. Mavilio, C. Bordignon
  • University Vita-Salute San Raffaele
  • Institute for Biomedical Research
  • MolMed S.p.A.
  • Imperial College London
  • San Raffaele Telethon Institute for Gene Therapy
  • Indiana University School of Medicine
  • University Medical Center Utrecht
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • University of Modena
  • Hannover Medical School
  • CIEMAT Energy Department
  • Leiden University Medical Centre
  • Stem Cells Inc.
  • The University of Texas M. D. Anderson Cancer Center
  • Ist. Ric. Farmacol. Mario Negri
  • Hadassah Hebrew University Medical Center
  • University of Washington

Research output: Contribution to journalLetterpeer-review

165 Scopus citations
Original languageEnglish
Pages (from-to)367-369
Number of pages3
JournalNature Medicine
Volume9
Issue number4
DOIs
StatePublished - 1 Apr 2003
Externally publishedYes

Cite this